German Court Issues Compulsory License on HIV Drug Patent
A German patent court has ordered a compulsory license under Section 24 of the Patent Act, allowing Merck (US) to continue to market the HIV drug raltegravir (marketed as Isentress).
Access to Medicine
Commentary on Hillary Clinton’s Plan to Respond to Unjustified Price Hikes for Long-Available Drugs
Democratic presidential nominee Hillary Clinton has published a factsheet presenting, “Hillary’s Plan to Respond to Unjustified Price Hikes for Long-Available Drugs.”
Today via Twitter, KEI Director James Love offered a six point commentary on Secretary Clinton’s proposal to address drug price hikes:
SCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents
On 30 June 2016, the 24th session of the WIPO Standing Committee on the Law of Patents (SCP) agreed to an ambitious work program on patents and health, exceptions and limitations to patent rights, quality of patents, transfer of technology and confidentiality of communications between clients and their patent advisors.
On patents and health, the Committee agreed to the following:
Human Rights Council adopts watershed resolution on Access to Medicines
*(The author thanks Mirza Alas and Alexandre Gajardo for their notes of the 2nd round of informal consultations held on 22 June 2016 and Sophia Simon for transcribing the statements delegations made during the plenary discussions held on 1 July 2016.)
SCP 24 – A fruitful discussion?
30 June 2016
By Sophia Simon
The World Intellectual Property Organization’s (WIPO) Standing Committee on the Law of Patents (SCP) plays a significant role as the United Nation’s only dedicated, multilateral forum for the discussion on patents. The WIPO SCP convened for its 24th session in Geneva from 27 June 2016 to 30 June 2016.
SCP24: African Group submits revised proposal for a WIPO work program on Patents and Health
On Wednesday morning, 29 June 2016, Nigeria, on behalf of the African Group, presented a revised proposal (SCP/24/4) for a WIPO work program on Patents and Health at the Standing Committee on the Law of Patents (SCP). The African Group proposal is a welcome breath of fresh air in the patent committee; the proposal aims to make WIPO more responsive to recent developments including: 1) “Challenges to public health …. Continue Reading
Human Rights Council heats up during informal talks on the primacy of human rights over international trade and IP regimes
At the 32nd session (13 June 2016 – 1 July 2016) of the Human Rights Council, a bloc of countries known as the the Core Group (Brazil, Egypt, Indonesia, India, Senegal, South Africa and Thailand) have tabled a resolution on access to medicines “premised on the primacy of human rights over international trade, investment and intellectual property regimes.” The draft resolution complements the work of the United Nations High-Level Panel on Access to Medicines in reviewing and assessing “proposals and recommend solutions for remedying the policy incoherence between the justifiable rights of inven Continue Reading
2016: Chimeron Bio: KEI comments on NIH proposal for exclusive license for patents on cancer treatments
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 18th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Chimeron… Continue Reading
2016: KEI comments on NIH proposal for exclusive licenses to Dimension Therapeutics, Inc.
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 24th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Dimension… Continue Reading
2016: KEI comments on NIH proposal for exclusive licenses to Etubics Corporation
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 19th, 2016 the NIH posted a notice on the Federal Register stating it is contemplating the grant of an exclusive license to Etubics… Continue Reading